Tag: #Global Trends

Life science leaders Chitose Laboratory Corp. and Fujifilm Biosciences Inc. have officially formed a strategic alliance. This partnership aims to... Read more

The U.S. Food and Drug Administration (FDA) has officially granted approval for Rybrevant Faspro, a therapy targeting epidermal growth factor... Read more

Nxera Pharma (formerly Sosei Group) is actively seeking buyers or strategic partners for its schizophrenia drug program after Boehringer Ingelheim... Read more

Pharmaceutical giant Eli Lilly has released Phase III (ATTAIN-MAINTAIN) data for orforglipron, an oral GLP-1 receptor agonist. The drug is... Read more

In a landmark move, nine multinational pharmaceutical companies have signed agreements with the White House to lower prices for various... Read more

Researchers at Binghamton University (USA) have announced a breakthrough approach in developing cancer treatment vaccines. By combining mRNA technology with... Read more

Xoma Royalty, a company that has recently established a business strategy centered on acquiring distressed biotechnology firms, has secured its... Read more

On December 15, 2025, Sanofi announced two significant strategic collaborations aimed at strengthening its advanced therapeutic development pipelines. 1. Agreement... Read more

The global pharmaceutical corporation, Pfizer, has issued a revenue projection for 2026 in the range of $59.5 billion to $62.5... Read more